| Unique ID issued by UMIN | UMIN000062041 |
|---|---|
| Receipt number | R000070989 |
| Scientific Title | Single-ingredient Vitamin D3 3200 IU versus Vitamin D3 3200 IU/Zinc/Quercetin Supplementation in Adult Indonesian Women: A Pilot Randomized Controlled Trial |
| Date of disclosure of the study information | 2026/06/24 |
| Last modified on | 2026/06/24 12:43:12 |
Single-ingredient Vitamin D3 3200 IU versus Vitamin D3 3200 IU/Zinc/Quercetin Supplementation in Adult Indonesian Women: A Pilot Randomized Controlled Trial
Single vs Vitamin D Combination: A Pilot RCT
Single-ingredient Vitamin D3 3200 IU versus Vitamin D3 3200 IU/Zinc/Quercetin Supplementation in Adult Indonesian Women: A Pilot Randomized Controlled Trial
Single vs Vitamin D Combination: A Pilot RCT
| Asia(except Japan) |
vitamin D deficiency/insufficiency in healthy adult Indonesian women
| Medicine in general |
Others
NO
To evaluate and compare the effectiveness of a vitamin D combination formulation (vitamin D3, zinc bisglycinate, and quercetin phytosome) versus vitamin D3 monotherapy in improving vitamin D status, immunological markers, hematological parameters, and body composition in healthy Indonesian adult women.
Safety,Efficacy
Change in serum 25-hydroxyvitamin D [25(OH)D] levels from baseline to 8 weeks after supplementation
- Changes in hematological parameters (hemoglobin, hematocrit, erythrocyte count, leukocyte count)
- Changes in body composition (body fat percentage, visceral fat, muscle mass, total body water)
- Correlation between changes in vitamin D levels and immunometabolic parameters
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Prevention
| Other |
Intervention group: Vitamin D3 3200 IU combined with zinc bisglycinate and quercetin phytosome (Imune), administered orally once daily for 8 weeks
Control group: Vitamin D3 3200 IU monotherapy, administered orally once daily for 8 weeks.
| 18 | years-old | <= |
| 65 | years-old | > |
Female
Healthy adult women aged 18-65 years
No history of chronic disease( e.g cardiovascular, liver, kidney, diabetes, autoimnune disorders)
Not taking vitamin D supplementation within at least 2 weeks prior to study
Willing to participate and provide informed consent
Pregnancy or breastfeeding
Use of medications affecting vitamin D metabolism (e.g., corticosteroids, antiepileptics, statins, metformin)
Presence of chronic illnesses
Current participation in other clinical studies
86
| 1st name | Linawati |
| Middle name | |
| Last name | Hananta |
Faculty of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya
Pharmacology
14440
Jl. Pluit Raya No. 2, Penjaringan, North Jakarta 14440, Special Capital Region of Jakarta, Indonesia.
+6281383777800
linawati.hananta@atmajaya.ac.id
| 1st name | Linawati |
| Middle name | |
| Last name | Hananta |
Faculty of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya
Pharmacology
14440
Jl. Pluit Raya No. 2, Penjaringan, North Jakarta 14440, Special Capital Region of Jakarta, Indonesia
+6281383777800
linawati.hananta@atmajaya.ac.id
Three International Wellness Technology Indonesia.
Three International Wellness Technology Indonesia.
Outside Japan
School of Medicine and Health Sciences Atma Jaya Catholic University of Indonesia
Jl. Pluit Raya No. 2, Penjaringan, North Jakarta 14440, Special Capital Region of Jakarta, Indonesia
+62 21 669 3168
kep.fkik@atmajaya.ac.id
NO
| 2026 | Year | 06 | Month | 24 | Day |
Unpublished
86
Completed
| 2025 | Year | 05 | Month | 09 | Day |
| 2025 | Year | 05 | Month | 09 | Day |
| 2025 | Year | 08 | Month | 01 | Day |
| 2025 | Year | 10 | Month | 30 | Day |
| 2026 | Year | 06 | Month | 24 | Day |
| 2026 | Year | 06 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070989